Q32 Bio (QTTB) Revenue Growth (1y) (2019 - 2023)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 64.24% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 7.82% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 19.04% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 3,790.58% |
| 10 | Q32 Bio | 162.94 Mn | 112.19 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -269.58% |
| Sep 30, 2023 | 131.80% |
| Jun 30, 2023 | 299.63% |
| Mar 31, 2023 | 267.46% |
| Dec 31, 2022 | 0.00% |
| Sep 30, 2022 | -52.18% |
| Jun 30, 2022 | -63.33% |
| Mar 31, 2022 | -97.26% |
| Dec 31, 2021 | -18.16% |
| Sep 30, 2021 | 195.77% |
| Jun 30, 2021 | 285.71% |
| Mar 31, 2021 | 4,883.84% |
| Dec 31, 2020 | 74.07% |
| Sep 30, 2020 | 28.57% |
| Jun 30, 2020 | 44.64% |
| Mar 31, 2020 | 117.78% |
| Dec 31, 2019 | -52.93% |
| Sep 30, 2019 | -72.47% |
| Jun 30, 2019 | -71.90% |
| Mar 31, 2019 | -76.09% |